{"created":"2023-06-23T12:19:17.147030+00:00","id":10171,"links":{},"metadata":{"_buckets":{"deposit":"5a26aba1-7425-4328-8afb-16c3c20bd83f"},"_deposit":{"created_by":19,"id":"10171","owners":[19],"pid":{"revision_id":0,"type":"depid","value":"10171"},"status":"published"},"_oai":{"id":"oai:asahi-u.repo.nii.ac.jp:00010171","sets":["64:123"]},"author_link":["13645"],"item_10_creator_30":{"attribute_name":"教員氏名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"大橋, たみえ"}],"nameIdentifiers":[{"nameIdentifier":"13645","nameIdentifierScheme":"WEKO"}]}]},"item_10_date_36":{"attribute_name":"発行又は発表の年月","attribute_value_mlt":[{"subitem_date_issued_datetime":"2018-06-15"}]},"item_10_textarea_29":{"attribute_name":"業績分類","attribute_value_mlt":[{"subitem_textarea_value":"学会発表"}]},"item_10_textarea_31":{"attribute_name":"発行、発表雑誌等、又は発表学会等の名称","attribute_value_mlt":[{"subitem_textarea_value":"第54回日本肝臓学会総会"}]},"item_10_textarea_35":{"attribute_name":"単著、共著の別","attribute_value_mlt":[{"subitem_textarea_value":"共同"}]},"item_10_textarea_42":{"attribute_name":"概要","attribute_value_mlt":[{"subitem_textarea_value":"G/P併用療法はSVR１２は１００％であり、治療完遂率も１００％であった。本療法は既存薬よりも効果と安全性が高く、今後の標準治療となる可能性が高い。"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Glecaprevir+Pibrentasvir併用療法の早期治療効果および安全性に関する検討（多施設共同研究）","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Glecaprevir+Pibrentasvir併用療法の早期治療効果および安全性に関する検討（多施設共同研究）"}]},"item_type_id":"10","owner":"19","path":["123"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-01-18"},"publish_date":"2019-01-18","publish_status":"0","recid":"10171","relation_version_is_last":true,"title":["Glecaprevir+Pibrentasvir併用療法の早期治療効果および安全性に関する検討（多施設共同研究）"],"weko_creator_id":"19","weko_shared_id":-1},"updated":"2023-06-23T13:35:23.106062+00:00"}